Bilirubin-corrected creatinine: why there is no formula and how to assess the interference
What bilirubin interference in creatinine is
Bilirubin is a known interferent in serum creatinine measurement. In icteric samples, the pigment alters the colorimetric reading and the result no longer reflects only the patient's creatinine.
The effect depends on the method. The KDIGO 2024 guideline on chronic kidney disease notes that enzymatic assays are more specific for creatinine and less susceptible to chromogenic interference, such as icterus and hemolysis, than the Jaffe method, and recommends the enzymatic method whenever possible.
A Swiss study (Frey and colleagues), with 15,618 samples, compared the Jaffe and enzymatic assays from the same manufacturer. Without icterus, the mean difference was 3.97%. With bilirubin between 5 and 20 mg/dL, it was 10.9%; between 20 and 53 mg/dL, it reached 43.4%. The authors concluded that the difference may lead to underestimating kidney function.
The problem matters most in patients with liver disease, who often have high bilirubin and need reliable creatinine. The AST/ALT ratio is part of the same liver assessment.
Why the calculator does not calculate a corrected creatinine
The tool applies no correction factor, a decision based on the sources. Three reasons support the choice:
- The direction of the error changes with the reagent. Studies with the classic Jaffe method describe negative interference, which lowers creatinine. In the study by Frey and colleagues, with one manufacturer's recent-generation Jaffe reagent, values were higher than those of the enzymatic method in highly icteric samples.
- The size of the error also changes. The mean differences cited apply to one pair of reagents on a single analyzer and do not transfer to other systems.
- The published solution is analytical. KDIGO 2024 recommends the enzymatic method, and techniques such as preincubation with sodium hydroxide reduce the error within the assay itself.
The calculator does not apply any sex factor to creatinine, because that adjustment has no relation to bilirubin. Equations such as the eGFR by CKD-EPI 2021 already adjust for sex in their own coefficients.
How to use the calculator: inputs, units and calculations
The calculator asks for three inputs from the same sample:
- Measured serum creatinine, in mg/dL, greater than zero and up to 30 mg/dL.
- Total bilirubin, in mg/dL, from 0 to 80 mg/dL.
- Creatinine method: Jaffe, enzymatic or “not sure” (default option).
With these inputs, it shows:
- creatinine in µmol/L, multiplying mg/dL by 88.4, a factor from the KDIGO 2024 conversion table;
- bilirubin in µmol/L, multiplying mg/dL by 17.1, a factor derived from the molar mass of bilirubin (584.7 g/mol);
- the bilirubin range from the study by Frey and colleagues (below 5, 5 to 20 and 20 mg/dL or more), with the mean difference between methods observed in each range;
- guidance according to the method entered.
Creatinine (µmol/L) = creatinine (mg/dL) × 88.4
Bilirubin (µmol/L) = bilirubin (mg/dL) × 17.1
Values outside the accepted ranges, such as zero creatinine or negative bilirubin, produce an error message saying what to correct.
Worked example with the calculator
Hypothetical case: creatinine of 1.2 mg/dL measured by the Jaffe method, in a sample with total bilirubin of 12 mg/dL.
- Creatinine in SI units: 1.2 × 88.4 = 106.08, displayed as 106 µmol/L.
- Bilirubin in SI units: 12 × 17.1 = 205.2, displayed as 205 µmol/L.
- Range: 12 mg/dL is between 5 and 20, “interference possible”. In the study by Frey and colleagues, the mean difference between Jaffe and enzymatic in this range was 10.9%.
- Guidance for Jaffe: ask the laboratory for an enzymatic measurement.
The calculator returns exactly these values and texts. Note that it does not turn 1.2 into another number: a mean difference of 10.9% in one study does not say how much, or in which direction, this sample was wrong with this reagent. The answer comes from a new measurement.
If the same sample had been measured by an enzymatic method, the range would be the same, but the guidance would be to check the reagent's interference limit.
How to understand the result and what to do next
The result indicates the risk that bilirubin has altered creatinine, not a corrected value.
- Below 5 mg/dL: in the reference study, Jaffe and enzymatic agreed well, with a mean difference of 3.97%.
- 5 to 20 mg/dL: the mean difference rose to 10.9%. With Jaffe, it is worth requesting an enzymatic measurement.
- 20 mg/dL or more: the mean difference reached 43.4% between 20 and 53 mg/dL. Jaffe creatinine should not be used without confirmation.
In any range, use the measured creatinine, preferably enzymatic, in kidney function equations. Do not apply your own factors before calculating the GFR by MDRD or CKD-EPI. In the presence of significant icterus, consult the laboratory: it can report the method, the sample's icterus index and the interference limit validated for the reagent. Interpreting kidney function is the responsibility of the professional caring for the patient.
Assay methods, common errors and checklist
The choice of assay method matters more than any calculation done afterward. The table summarizes the differences described in KDIGO 2024 and in the study by Frey and colleagues.
| Method | Principle | Bilirubin interference |
|---|---|---|
| Jaffe | Reaction of creatinine with alkaline picrate | More susceptible; the error grows with bilirubin and its direction depends on the reagent |
| Enzymatic | Sequence of specific enzymatic reactions | Lower, though not zero |
Common errors:
- applying a fixed factor to “correct” icteric creatinine;
- comparing creatinine values from different methods over time;
- using bilirubin from another sample;
- entering values in µmol/L in the mg/dL fields.
Checklist:
- Which method did the laboratory use, Jaffe or enzymatic?
- Is the bilirubin from the same sample?
- Does the report note icterus interference?
- Is the value going into the kidney function equation the measured one?
Comparison with other ways of assessing kidney function
Serum creatinine alone is only the starting point of the renal assessment. The KDIGO 2024 guideline recommends estimating the filtration rate with a validated equation, rather than using creatinine alone.
- eGFR by CKD-EPI 2021: uses creatinine, age and sex, without race. It is the equation recommended by the National Kidney Foundation.
- GFR by MDRD: an earlier equation, less accurate at filtration rates above 60 mL/min/1.73 m².
- Creatinine clearance with timed urine: measures creatinine in urine and blood. KDIGO 2024 considers the collection prone to error. See the creatinine clearance calculator.
- Cystatin C: another filtration marker, which is not affected by the chromogenic interference of bilirubin on creatinine. KDIGO 2024 suggests considering cystatin C equations in specific circumstances, alone or combined with creatinine.
In patients with icterus, all creatinine-based estimates inherit the method's interference. For that reason, verification starts in the laboratory.
Frequently asked questions about creatinine in samples with high bilirubin
Is there a formula to correct creatinine for bilirubin?
There is no validated universal formula. The size and direction of the error depend on the reagent and the analyzer. The approach recommended by KDIGO 2024 is to measure creatinine by an enzymatic method whenever possible.
Does bilirubin raise or lower creatinine?
It depends on the reagent. Studies with the classic Jaffe method describe lower values; in the study by Frey and colleagues, one manufacturer's Jaffe gave higher values than the enzymatic method in highly icteric samples, with a mean difference of 43.4% between 20 and 53 mg/dL of bilirubin.
What does the calculator calculate, then?
It converts creatinine (× 88.4) and bilirubin (× 17.1) to µmol/L, shows the bilirubin range with the mean difference between methods observed in the reference study and gives guidance according to the method entered.
Should a sex factor, such as 0.85, be applied to creatinine?
No. That factor has no source and no relation to bilirubin. Equations such as CKD-EPI 2021 already adjust for sex in their own coefficients, and applying a factor beforehand would count sex twice.
How can I get a reliable creatinine in an icteric patient?
Request measurement by an enzymatic method and check on the report whether the sample exceeded the reagent's interference limit. In selected cases, cystatin C is an alternative filtration marker.
References
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. View
- Frey K, Gawinecka J, von Eckardstein A, Saleh L. Bilirubin interference in creatinine assays: cross-sectional analysis of the impact on the MELD score and CKD staging using Jaffe vs enzymatic methods. Swiss Med Wkly. doi:10.57187/4707. View
Updated . A support tool for educational purposes; it does not replace clinical assessment.